PD-L1 expression on cancer cells (cut-off value: 1%) and immune cells (cut-off value: 10%) were detected in 12% and 28% of breast cancer samples, respectively, and high PD-L1 expression in immune cells predicted a better clinical course19. Here, CD274 is linked to breast cancer.